|
Orthologous residues
|
|
NUDE1 (human): T131‑p, NUDE1 iso2 (human): T131‑p, NUDE1 (mouse): T131‑p, NUDE1 iso3 (mouse): T131‑p, NUDE1 (rat): T131‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody
|
|
Disease tissue studied:
adrenal cancer, pheochromocytoma
|
|
Relevant cell lines - cell types - tissues:
COS (fibroblast), PC-12 (chromaffin)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
monkey
|
|
Comments:
PC-12 neuronal cell line (NS-1)
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
PKACa (human)
|
modification site within consensus motif, phospho-motif antibody, pharmacological activator of upstream enzyme, mutation in upstream enzyme recognition motif
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
|
|
DISC1 (human)
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation, protein conformation
|
|
Effect of modification (process):
cytoskeletal reorganization
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
PAFAH1B1 (human)
|
|
Disrupts
|
|
|
co-immunoprecipitation
|
|
NDEL1 (human)
|
|
Induces
|
protein conformation
|
|
co-immunoprecipitation
|
|
|
Comments:
T131 phoshomimetic mutant inhibits neurite extension.
|